ライフサイエンスコーパス: hemofiltration

1 irst patient received continuous veno-venous hemofiltration.

2 %FO) in the intensive care unit (ICU) before hemofiltration.

3 ately transitioned to continuous veno-venous hemofiltration.

4 and kidney transplantation and responded to hemofiltration.

5 Two patients required continuous venovenous hemofiltration, 1 of whom died and 1 of whom survived.

6 branes used in convective therapies, such as hemofiltration and hemodiafiltration.

7 ors can be removed from the circulation with hemofiltration and that adsorption plays an important ro

8 upport, vasopressors, continuous veno-venous hemofiltration, and blood product transfusions.

9 anically ventilated, nine were on continuous hemofiltration, and five required vasopressors.

10 ation cardiac arrest, continuous veno-venous hemofiltration, and hyperbilirubinemia during extracorpo

11 transport on ECLS, minimal anticoagulation, hemofiltration, and optimal systemic oxygen delivery.

12 luid removal by nontraditional peritoneal or hemofiltration approaches.

13 cial kidney (BAK) consists of a conventional hemofiltration cartridge in series with a renal tubule a

14 tificial kidney consisting of a conventional hemofiltration cartridge in series with a renal tubule a

15 The use of a modified continuous venovenous hemofiltration circuit for rewarming in a juvenile goat

16 imals were placed in a continuous venovenous hemofiltration circuit with either a sham RAD without ce

17 oxygenator (0.65 m) was inserted within the hemofiltration circuit, either upstream (n = 7) or downs

18 echnique of a modified continuous venovenous hemofiltration circuit.

19 armed using a modified continuous venovenous hemofiltration circuit.

20 s were connected to a continuous veno-venous hemofiltration (CVVH) (filtration: 80 ml/kg/h) or sham c

21 s is not equivalent on continuous venovenous hemofiltration (CVVH) compared with continuous venovenou

22 Continuous venovenous hemofiltration (CVVH) is used for renal replacement and

23 F-80 dialyzers during continuous venovenous hemofiltration (CVVH) or continuous venovenous hemodialy

24 Continuous venovenous hemofiltration (CVVH) represents a potential source of c

25 nstrates that the combination of a synthetic hemofiltration device and a renal tubule cell therapy de

26 High-volume, continuous hemofiltration during CPB attenuates systemic edema form

27 mmediately placed in a continuous venovenous hemofiltration extracorporeal circuit with either a sham

28 n failure and required continuous venovenous hemofiltration for 16 days.

29 amine have shown that it is ineffective, and hemofiltration has become increasingly popular as a choi

30 al substitution therapy with hemodialysis or hemofiltration has been the only successful long-term ex

31 Hemofiltration (HF) could potentially remove inflammator

32 High volume hemofiltration (HVHF) (200 ml/kg/h) improves hemodynamic

33 d correcting metabolic acidosis, high-volume hemofiltration (HVHF) might halt the vicious circle lead

34 nstrate that the addition of cell therapy to hemofiltration in an acutely uremic animal model with se

35 poreal CO2 removal and continuous venovenous hemofiltration in patients with acute respiratory distre

36 Continuous hemofiltration may be used in patients with fulminant he

37 of patients receiving continuous veno-venous hemofiltration or continuous venovenous hemofiltration w

38 e undergone aggressive continuous venovenous hemofiltration or hemodiafiltration at Brooke Army Medic

39 on (2C); equivalency of continuous veno-veno hemofiltration or intermittent hemodialysis (2B); prophy

40 (1A); equivalency of continuous veno-venous hemofiltration or intermittent hemodialysis (2B); prophy

41 echanical fluid removal via ultrafiltration, hemofiltration, or hemodialysis may be needed for refrac

42 orty patients received continuous venovenous hemofiltration + RAD, and 18 received CRRT alone.

43 uids should be administered judiciously, and hemofiltration should be instituted early to remove flui

44 Continuous venovenous hemofiltration therapy was titrated to maintain maximum

45 cal application of human progenitor cells in hemofiltration units, and additional studies may ultimat

46 taneously placed catheter and hepatic venous hemofiltration using a double balloon catheter positione

47 our throughout CPB, simultaneously replacing hemofiltration volume with a balanced salt solution (HF

48 In 8 control animals, no hemofiltration was performed.

49 nous hemofiltration or continuous venovenous hemofiltration with a 0.9-m2 polyacrylonitrile filter at

50 The bioartificial kidney, combining hemofiltration with a device containing human tubular ce

51 We used continuous venovenous hemofiltration with dialysis following hepatectomy with

52 ncluding hemoperfusion, plasma exchange, and hemofiltration with hemoperfusion were associated with l